Nucleic Acid Aptamers Market: Challenges and Opportunities
Nucleic acid aptamers are species of nucleic acid that are engineered in in vitro selection or SELEX i.e. systematic evolution of ligands by exponential enrichment. Aptamers bind different molecular targets such as proteins, nucleic acids, cells, organisms and other molecules and assist in molecular recognition of certain characters that fight antibodies. Aptamers have remarkable advantage over antibodies as they can be easily produced through chemical synthesis and can be engineered in vitro. Aptamers are commonly developed as ligands offering molecular...
View full press release